ArticleFrontiers in psychiatry2026
Integrating multi-atlas neuroimaging data for robust biomarker identification in neuropsychiatric disorders.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate diagnosis of neuropsychiatric disorders like autism spectrum disorder (ASD) and post-traumatic stress disorder (PTSD) is challenging due to complex disruptions in brain functional connectivity. Existing graph neural network (GNN) methods are often limited by reliance on single-atlas representations. Methods: We propose MSAT-LAFFNet, a multi-atlas GNN framework integrating a Structure-Aware Graph Transformer (SAT) for enhanced structural encoding and a Lightweight Attentional Feature Fusion network (LAFFNet) for adaptive cross-atlas fusion. The model was validated on the public ABIDE-I dataset and a private PTSD dataset (n=138). Results: Our model achieved an AUC of 82.9%/accuracy of 81.59% on ABIDE-I (ASD) and an AUC of 89.96%/accuracy of 89.45% on the PTSD dataset, outperforming competing methods. Interpretability analysis identified disorder-specific overlapping abnormal regions, including the right middle frontal gyrus in ASD and the left amygdala in PTSD, linking them to known network dysfunctions. Conclusion: MSAT-LAFFNet demonstrates superior classification performance and provides neurobiologically interpretable findings, showing potential as an effective tool for the auxiliary diagnosis of disorders characterized by disrupted functional networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.